Neonatal mitochondrial abnormalities due to PINK1 deficiency: Proteomics reveals early changes relevant to Parkinson׳s disease
Parkinson׳s disease (PD), the second most common neurodegenerative disorder, affects roughly 7–10 million people worldwide. A wide array of research has suggested that PD has a mitochondrial component and that mitochondrial dysfunction occurs well in advance of the clinical manifestation of the dise...
Main Authors: | Lance M. Villeneuve, Phillip R. Purnell, Kelly L. Stauch, Howard S. Fox |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-03-01
|
Series: | Data in Brief |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340915003704 |
Similar Items
-
Data for mitochondrial proteomic alterations in the aging mouse brain
by: Kelly L. Stauch, et al.
Published: (2015-09-01) -
SWATH-MS proteome profiling data comparison of DJ-1, Parkin, and PINK1 knockout rat striatal mitochondria
by: Kelly L. Stauch, et al.
Published: (2016-12-01) -
Data for mitochondrial proteomic alterations in the developing rat brain
by: Lance M. Villeneuve, et al.
Published: (2014-12-01) -
Proteomic and functional data sets on synaptic mitochondria from rats with genetic ablation of Parkin
by: Lance M. Villeneuve, et al.
Published: (2018-10-01) -
Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration.
by: Suzana Gispert, et al.
Published: (2009-06-01)